(Q38170150)

30 August 2017

title

Cellular and molecular mechanisms in cancer immune escape: a comprehensive review (English)

1 reference

evasion of host immune response

30 August 2017

main subject

1 reference

Alka Bhatia

1

1 reference

30 August 2017

Yashwant Kumar

series ordinal

2

1 reference

30 August 2017

publication date

10 December 2013

1 reference

Expert Review of Clinical Immunology

30 August 2017

published in

1 reference

30 August 2017

volume

10

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

41-62

1 reference

Spectrum of cancer risk among US solid organ transplant recipients

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Cancer burden in the HIV-infected population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Expression of tumour-specific antigens underlies cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Fas gene mutation in the progression of adult T cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: mechanism for immune evasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Modulation of T-cell activation by malignant melanoma initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Regulation of cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Lipid accumulation and dendritic cell dysfunction in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Prostaglandins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

HLA-G gene activation in tumor cells involves cis-acting epigenetic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Role of gene methylation in antitumor immune response: implication for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Activation of Akt as a mechanism for tumor immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Heat shock proteins: conditional mediators of inflammation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Differential heat shock protein localization in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Clinical and biological significance of HSP89 alpha in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Expression and roles of heat shock proteins in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Negative regulation of the Apaf-1 apoptosome by Hsp70

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

In vivo functions of the Saccharomyces cerevisiae Hsp90 chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Dendritic cells in the cancer microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Mechanisms of loss of HLA class I expression on colorectal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The B7 family and cancer therapy: costimulation and coinhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

B7x: a widely expressed B7 family member that inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

B7S1, a novel B7 family member that negatively regulates T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

B7x and myeloid-derived suppressor cells in the tumor microenvironment: A tale of two cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Ovarian cancer cells modulate human blood neutrophils response to activation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Myeloid-Derived Suppressor Cells in Human Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

L-arginine availability regulates T-lymphocyte cell-cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Inhibition of MHC II gene transcription by nitric oxide and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Reactive oxygen species as intracellular messengers during cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Myeloid-derived suppressor cells: a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Impaired interferon signaling is a common immune defect in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The role of vascular cell adhesion molecule-1 in tumor immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Cytokine patterns in patients with cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

IL-23 promotes tumour incidence and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Human tumor-derived exosomes down-modulate NKG2D expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Anti-cancer therapies targeting the tumor stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Coinhibitory molecules in cancer biology and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Releasing the brake on the immune system: ipilimumab in melanoma and other tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Agonist antibodies to TNFR molecules that costimulate T and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

RNA pulsed dendritic cells: an approach for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Targeting the dynamic HSP90 complex in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Cytokine induced killer cells as promising immunotherapy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Phase I clinical trial of a TGF-beta antisense-modified tumor cell vaccine in patients with advanced glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Combating immunosuppression in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

21 January 2018

Here, there, everywhere?

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.865519

10.1586/1744666X.2014.865519

21 January 2018

Identifiers

DOI

1 reference

release_mxrobg2zhnb3vhipgfebkh77l4

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mxrobg2zhnb3vhipgfebkh77l4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference